| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2024 Q2 | Aug 6, 2024 | Long Cast Advisers | 6.0% | 16.0% | MTRX, RSSS | - | View | ||
| 2024 Q2 | Jul 14, 2024 | Aegis Value Fund | 0.0% | 3.1% | ARG CN, BOCH LN, DLAPQ, IFP CN, MTRX, ORE CN, PRU CN | - | View | ||
| 2024 Q1 | May 7, 2024 | Long Cast Advisers | 6.0% | 16.0% | CCRD, MTRX, PESI, QRHC, SNES | - | View | ||
| 2025 Q3 | Nov 24, 2025 | Long Cast Advisers | 4.0% | -1.0% | MTRX, PDEX, PESI, QRHC, RSSS | Compounding, industrials, Inefficiency, SmallCaps, valuation | The manager reiterates that small-cap inefficienciesparticularly in niche industrials and underfollowed service companiescreate persistent mispricings. The letter shows several examples where revenue durability and strong balance sheets remain underappreciated by the market despite cyclical noise. Small caps remain attractive for patient investors seeking idiosyncratic compounders with valuation dislocations. | QRHC PESI RSSS MTRX PDEX |
View |
| 2025 Q4 | Jan 24, 2026 | Long Cast Advisers | 1.0% | 0.0% | CCRD, CCRN, EEFT, LSYN, MAMA, MTRX, NRC, PDEX, PESI, QRHC, RELL, RSSS | healthcare, Owner-Operator, small caps, Staffing, value | Significant focus on healthcare staffing through CCRN investment, with nurse staffing industry facing competitive pressures but potential for margin improvement. Also invested in NRC, a healthcare consulting and patient survey company with strong margins despite industry headwinds. Portfolio concentrated in small and micro-cap companies with intent to own for multiple years. Manager emphasizes patient capital approach targeting 15% annualized returns through well-researched small company investments. Focus on companies trading at attractive valuations with strong balance sheets and cash positions. CCRN example shows investment in company with 40% of market cap in cash and low enterprise value multiples. | RSSS MTRX NRC CCRN |
View |
| 2023 Q1 | Aug 5, 2023 | Long Cast Advisers | 6.0% | 16.0% | MTRX, PESI | - | View | ||
| 2023 Q4 | Feb 13, 2024 | Long Cast Advisers | 6.0% | 16.0% | CCRD, MAMA, MTRX, PESI, QRHC, RSSS | - | View | ||
| 2024 Q4 | Jan 24, 2025 | Long Cast Advisers | 20.0% | 39.0% | CCRD, MTRX, PDEX, PESI, QRHC, RSSS | - | View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Jan 27, 2026 | Fund Letters | Avram Fisher | Matrix Service Company | Industrials | Construction & Engineering | Bull | NASDAQ | backlog, engineering, infrastructure, operating leverage, turnaround | View Pitch |
| Nov 28, 2025 | Fund Letters | Avram Fisher | Matrix Service Company | Industrials | Engineering & Construction Services | Bull | NASDAQ | construction, Cyclical, EBITDA, energy, infrastructure, rerating, turnaround | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||